English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study Journal article
Yang, Liang, Niu, Zhen, Ma, Zhixuan, Wu, Xiaojie, Vong, Chi Teng, Li, Ge, Feng, Ying. Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study[J]. Cancer Cell International, 2024, 24(1), 323.
Authors:  Yang, Liang;  Niu, Zhen;  Ma, Zhixuan;  Wu, Xiaojie;  Vong, Chi Teng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/10/10
Diagnosis  Exosomal Micrornas  Glioma  Prognosis  Treatment  
Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells Journal article
Cai, Wanhua, Rong, Dade, Ding, Jiayu, Zhang, Xiaomei, Wang, Yuwei, Fang, Ying, Xiao, Jing, Yang, Shulan, Wang, Haihe. Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells[J]. Cancer Cell International, 2024, 24(1), 249.
Authors:  Cai, Wanhua;  Rong, Dade;  Ding, Jiayu;  Zhang, Xiaomei;  Wang, Yuwei; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.3/5.0 | Submit date：2024/08/05
Breast Cancer  Er Stress  Perk/eif2α  Taxane  Tumor Drug Resistance  
AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers Journal article
Lin, Ziqi, Pan, Rulu, Wu, Liyue, Zhu, Fangsheng, Fang, Qiwei, Kwok, Hang Fai, Lu, Xincheng. AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers[J]. Cancer Cell International, 2024, 24(1), 283.
Authors:  Lin, Ziqi;  Pan, Rulu;  Wu, Liyue;  Zhu, Fangsheng;  Fang, Qiwei; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.3/5.0 | Submit date：2024/09/03
Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes Journal article
Wang, Kewei, Li, Zixi, Xuan, Ying, Zhao, Yong, Deng, Chao, Wang, Meidan, Xie, Chenjun, Yuan, Fenglai, Pang, Qingfeng, Mao, Wenjun, Cai, Dongyan, Zhong, Zhangfeng, Mei, Jie. Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes[J]. Cancer Cell International, 2023, 23(1), 229.
Authors:  Wang, Kewei;  Li, Zixi;  Xuan, Ying;  Zhao, Yong;  Deng, Chao; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.3/5.0 | Submit date：2024/01/02
Biomarker  Immunotherapy  Nfe2l2  Ngs  Nsclc  
Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling Journal article
He, Kancheng, Li, Zitaiyu, Ye, Kun, Zhou, Yihong, Yan, Minbo, Qi, Hao, Hu, Huating, Dai, Yingbo, Tang, Yuxin. Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling[J]. Cancer Cell International, 2022, 22(1).
Authors:  He, Kancheng;  Li, Zitaiyu;  Ye, Kun;  Zhou, Yihong;  Yan, Minbo; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:5.3/5.0 | Submit date：2023/01/30
Cisplatin  Metformin  Sequential Treatment  Testicular Germ Cell Tumour  Yap1